David J Cohen MD
Adult Congenital Heart Disease, Interventional Cardiology
Professor, Internal Medicine, University of Missouri, Kansas City School of Medicine
Join to View Full Profile
100 Port Washington BlvdSte 105Roslyn, NY 11576
Phone+1 516-390-9640
Fax+1 816-756-3645
Dr. Cohen is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Beth Israel Deaconess Medical CenterFellowship, Cardiovascular Disease, 1989 - 1994
Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 1986 - 1989
Harvard Medical SchoolClass of 1986
Certifications & Licensure
MA State Medical License 1989 - 2027
MO State Medical License 2006 - 2027
NY State Medical License 2020 - 2027
KS State Medical License 2006 - 2022
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Interventional Cardiology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2015-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory EHR Suite, Epic Systems Corporation, 2015-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2015-2017
Publications & Presentations
PubMed
- Angiography-Derived Fractional Flow Reserve to Guide PCI.William F Fearon, Allen Jeremias, Guy Witberg, Rasha Al-Lamee, David J Cohen
The New England Journal of Medicine. 2026-07-02 - Impact of Adverse Events on Costs and Length of Stay Following Transcatheter Tricuspid Valve Replacement.Matthew R Reynolds, Pinak B Shah, Susheel K Kodali, Rebecca T Hahn, Vinod H Thourani
Structural Heart. 2026-07-01 - Design and rationale of the prospective, randomized, controlled trial to assess the management of moderate aortic stenosis by clinical surveillance or transcatheter ao...Philippe Généreux, Raj R Makkar, Jeroen J Bax, Philippe Pibarot, Brian R Lindman
American Heart Journal. 2026-07-01
Journal Articles
- Coronary Health Status Benefits of Successful Chronic Total Occlusion Revascularization Across the Spectrum of Left Ventricular Function: Insights from the OPEN-CTO Re...David J Cohen, Sophia Airhart, J Aaron Grantham, Adam C Salisbury, James M McCabe, John A Spertus, ScienceDirect
- Original Investigation Stroke After Surgical Versus Transfemoral Transcatheter Aortic Valve Replacement in the PARTNER TrialEugene H Blackstone, Vinod H Thourani, Howard C Herrmann, David J Cohen, Michael J Mack, Raj R Makkar, Samir R Kapadia, Susheel K Kodali, Lars G Svensson, Molly Szerli..., ScienceDirect
- Original Investigations Long-Term Survival Following Multivessel Revascularization in Patients with Diabetes (FREEDOM Follow-on Study)Michael Domanski, Samin K Sharma, David J Cohen, Valentin Fuster, George D Dangas, ScienceDirect
Authored Content
- Less Is Still More in Patients with Acute Myocardial Infarction and Cardiogenic ShockAugust 2018
- Reply Cost-Effectiveness of Long-Term Ticagrelor in Patients with Prior Myocardial Infarction: Analysis by SubgroupsJanuary 2018
Press Mentions
Now Published: PREVUE-VALVE Charts the Prevalence of Valve Disease in the United StatesJune 16th, 2026- TCT 2025: PREVUE-VALVE Study Indicates Burden of Valvular Heart Disease in Adults Aged 65-85 YearsOctober 29th, 2025
- STRIVE: Low-Dose Alteplase Ineffective in STEMI Patients with Large ThrombusOctober 28th, 2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
